Hydraulic actuation device in motor vehicles
    29.
    发明授权
    Hydraulic actuation device in motor vehicles 失效
    汽车液压驱动装置

    公开(公告)号:US06854271B2

    公开(公告)日:2005-02-15

    申请号:US10401621

    申请日:2003-03-28

    摘要: A pressure cylinder for a hydraulic actuation device in motor vehicles includes a housing (1) with an internal cylinder (2,3). A piston (6) is displaceable in the internal cylinder for forming a pressure space (12) for a hydraulic fluid. The piston includes a hemispherical socket (10) in an indentation (9). A spring (18) is arranged in the pressure space (12), and a tappet (7) is connected by a transmission part with a hemispherical cap (8). The tappet (7) is in a frictional and swivelable engagement in the socket (10) in an indentation (9) by the force of the spring (18). The piston is a deep-drawn, cup-shaped part and includes a filling piece (13) in the interior of the piston (6). An annular space (15) is disposed at a piston surface (14) facing toward the pressure space (12). The annular space (15) is for receiving the spring (18) in a compressed state when the piston (6) is in a top dead center position.

    摘要翻译: 用于机动车辆中的液压致动装置的压力缸包括具有内筒(2,3)的壳体(1)。 活塞(6)可在内筒中移位,以形成用于液压流体的压力空间(12)。 活塞包括位于凹陷(9)中的半球形插座(10)。 弹簧(18)布置在压力空间(12)中,并且挺杆(7)通过具有半球形帽(8)的传动部分连接。 挺杆(7)通过弹簧(18)的力在凹部(9)中在插座(10)中以摩擦和可旋转的方式接合。 活塞是深冲的杯形部件,并且在活塞(6)的内部包括填充件(13)。 环形空间(15)设置在面向压力空间(12)的活塞表面(14)处。 当活塞(6)处于上止点位置时,环形空间(15)用于在压缩状态下接纳弹簧(18)。

    3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors
    30.
    发明授权
    3-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitors 失效
    (氨基或酰氨基)-1-(联苯基或苯基噻唑基)羰基哌啶衍生物作为食欲素受体抑制剂

    公开(公告)号:US08133901B2

    公开(公告)日:2012-03-13

    申请号:US12517010

    申请日:2007-11-29

    摘要: The invention relates to piperidine compounds of formula (I): wherein X—R1 represents —N(H)-pyrimidinyl, wherein said pyrimidinyl is unsubstituted or mono-substituted wherein the substituent is selected from (C1-4)alkyl or halogen, or X—R1 represents —NH—C(O)-heterocyclyl, wherein the heterocyclyl is selected from benzofuranyl and imidazo[2,1-b]-thiazolyl, wherein said heterocyclyl is unsubstituted or independently mono-, di- or tri-substituted wherein the substituents are independently selected from (C1-4)alkyl; A represents a phenyl- or thiazolyl-group, wherein the phenyl or thiazolyl is unsubstituted or mono-substituted with (C1-4)alkyl; B represents a phenyl-group, wherein the phenyl is unsubstituted or mono-, or di- substituted, wherein the substituents are independently selected from the group consisting of (C1-4)alkyl, (C1-4)alkoxy, trifluoromethyl, cyano and halogen; to pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.

    摘要翻译: 本发明涉及式(I)的哌啶化合物:其中X-R 1表示-N(H) - 嘧啶基,其中所述嘧啶基是未取代的或单取代的,其中取代基选自(C 1-4)烷基或卤素,或 X-R1表示-NH-C(O) - 杂环基,其中杂环基选自苯并呋喃基和咪唑并[2,1-b] - 噻唑基,其中所述杂环基是未取代的或独立的单 - ,二 - 或三 - 取代,其中 取代基独立地选自(C 1-4)烷基; A表示苯基或噻唑基,其中苯基或噻唑基未被取代或被(C 1-4)烷基单取代; B表示苯基,其中苯基是未取代的或单取代或二取代的,其中取代基独立地选自(C 1-4)烷基,(C 1-4)烷氧基,三氟甲基,氰基和 卤素; 和其药学上可接受的盐,以及这些化合物的用途用作药物,特别是作为食欲素受体拮抗剂。